Retina Associates St. Louis (site 300) — Florissant, Missouri

Retina Associates St. Louis (site 300) is a clinical research site located in Florissant, Missouri, United States 63031.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Retina Associates St. Louis (site 300) has participated in 1 clinical trials.

Therapeutic areas: Macular Degeneration.

Sponsors: OPKO Health, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Florissant

Browse all research sites in Missouri · View every site in Florissant

• Siteman Cancer Center-North County
• Healthcare Research
• Research Site
• Pfizer Investigational Site
• Retina Associates of St. Louis
• Pharmacosmos Investigational Site
• Research Facility
• GSK Investigational Site
• Med Research One
• PrimeCare Research Associates
• 575
• David S Rosenberg

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Retina Associates St. Louis (site 300)?

Retina Associates St. Louis (site 300) has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Retina Associates St. Louis (site 300) conducted?

Retina Associates St. Louis (site 300) has 1 clinical trials on record. Their work covers Macular Degeneration.

Is Retina Associates St. Louis (site 300) accredited by Crixeo Clinical Trials?

Retina Associates St. Louis (site 300) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Retina Associates St. Louis (site 300)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.